Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Human CD88/C5AR1 Protein, N-His-SUMO

Recombinant Human CD88/C5AR1 Protein, N-His-SUMO from ProteoGenix; catalogue ARO-P11312; research use only.

SKU:
ABM141749-1
Manufacturer SKU
ARO-P11312
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Introduction to Recombinant Human CD88/C5AR1 Protein

Recombinant Human CD88/C5AR1 Protein, also known as C5a receptor 1 (C5AR1), is a protein that plays a crucial role in the immune system. This protein is encoded by the C5AR1 gene and is a member of the G protein-coupled receptor (GPCR) family. It is primarily expressed on the surface of immune cells, such as neutrophils, macrophages, and monocytes, and is involved in a variety of immune responses.

Structure of Recombinant Human CD88/C5AR1 Protein

The recombinant form of CD88/C5AR1 protein is produced through genetic engineering techniques, where the C5AR1 gene is inserted into a host cell, typically a bacterial or mammalian cell. The resulting protein is identical to the naturally occurring protein in terms of structure and function. The recombinant protein is typically produced in large quantities, making it a valuable tool for research and therapeutic purposes.

The structure of CD88/C5AR1 protein consists of seven transmembrane domains, with the N-terminus located on the extracellular side and the C-terminus on the intracellular side. This structure allows the protein to interact with other molecules, such as C5a, a complement protein that activates the immune response.

Activity of Recombinant Human CD88/C5AR1 Protein

The primary function of CD88/C5AR1 protein is to bind to C5a, a small peptide that is produced during the activation of the complement system. This binding triggers a signaling cascade within the cell, leading to various immune responses, including chemotaxis, degranulation, and production of inflammatory cytokines.

Chemotaxis is the process by which immune cells are attracted to the site of infection or injury. CD88/C5AR1 protein plays a crucial role in this process by guiding immune cells towards the source of C5a. This allows for a rapid and efficient response to potential threats.

CD88/C5AR1 protein also plays a role in degranulation, which is the release of enzymes and other substances from immune cells. This process helps to destroy pathogens and damaged cells at the site of infection or injury.

Furthermore, CD88/C5AR1 protein is involved in the production of inflammatory cytokines, which are signaling molecules that promote inflammation and recruit other immune cells to the site of infection or injury. This helps to amplify the immune response and eliminate potential threats.

Application of Recombinant Human CD88/C5AR1 Protein

Recombinant Human CD88/C5AR1 Protein has a wide range of applications in scientific research and medicine. One of the primary uses of this protein is in the study of immune responses and the development of new therapies for immune-related diseases.

For example, studies have shown that dysregulation of CD88/C5AR1 protein can contribute to the development of autoimmune diseases, such as rheumatoid arthritis and lupus. By studying the structure and function of this protein, researchers can gain a better understanding of these diseases and potentially develop targeted therapies to treat them.

In addition, recombinant CD88/C5AR1 protein is also used in the development of new drugs that target the complement system. By blocking the interaction between C5a and CD88/C5AR1, these drugs can inhibit the excessive immune response seen in conditions such as sepsis and acute respiratory distress syndrome.

Furthermore, recombinant CD88/C5AR1 protein has potential applications in cancer research. Studies have shown that this protein is overexpressed in certain types of cancer, and targeting it could potentially inhibit tumor growth

ProteoGenix catalogue number ARO-P11312. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 16.19 kDa; Fragment: Arg175-Arg206; Buffer: Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
CD88, C5AR1, C5R1, C5AR, C5a-R, C5aR, C5a anaphylatoxin chemotactic receptor 1, C5a anaphylatoxin chemotactic receptor
Host species
E. coli
Source organism
Human
Molecular weight
16.19 kDa
Sequence fragment
Arg175-Arg206
Sequence
RVVREEYFPPKVLCGVDYSHDKRRERAVAIVR
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P11312
UniProt accession
P21730
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£199.00£159.20